The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(Butylamino)-N-(2-chlorophenyl)pyrazine-2-carboxamide ID: ALA3355707
PubChem CID: 109272646
Max Phase: Preclinical
Molecular Formula: C15H17ClN4O
Molecular Weight: 304.78
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCNc1cnc(C(=O)Nc2ccccc2Cl)cn1
Standard InChI: InChI=1S/C15H17ClN4O/c1-2-3-8-17-14-10-18-13(9-19-14)15(21)20-12-7-5-4-6-11(12)16/h4-7,9-10H,2-3,8H2,1H3,(H,17,19)(H,20,21)
Standard InChI Key: WSKWLLPVZCJAAK-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
20.2085 -19.9741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6171 -20.6832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3913 -19.9741 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.2085 -21.3882 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.3913 -21.3882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9827 -20.6832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6171 -19.2692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2085 -18.5601 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.4343 -19.2692 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.8429 -19.9741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6601 -19.9741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0687 -20.6832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6601 -21.3882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8429 -21.3882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4343 -20.6832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0687 -19.2692 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
18.9827 -22.0973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.1655 -22.0973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7569 -21.3882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9397 -21.3882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5311 -20.6832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 2 0
2 4 2 0
4 5 1 0
5 6 2 0
3 6 1 0
7 8 2 0
7 9 1 0
1 7 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
10 15 2 0
11 16 1 0
9 10 1 0
18 19 1 0
19 20 1 0
20 21 1 0
17 18 1 0
5 17 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 304.78Molecular Weight (Monoisotopic): 304.1091AlogP: 3.59#Rotatable Bonds: 6Polar Surface Area: 66.91Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 1.54CX LogP: 3.01CX LogD: 3.01Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.80Np Likeness Score: -1.96
References 1. Zitko J, Servusová B, Janoutová A, Paterová P, Mandíková J, Garaj V, Vejsová M, Marek J, Doležal M, Doležal M.. (2015) Synthesis and antimycobacterial evaluation of 5-alkylamino-N-phenylpyrazine-2-carboxamides., 23 (1): [PMID:25438883 ] [10.1016/j.bmc.2014.11.014 ]